A founder spends years building through dilution, payroll pressure, board scrutiny, and difficult financings. The exit finally arrives, or the shares become liquid, and the celebration quickly turns into a tax planning meeting.
The first question is often not price, structure, or even timing. Does this stock qualify for QSBS?
The answer can change the economics of an exit in a very large way. Qualified Small Business Stock, under Section 1202, may allow eligible noncorporate shareholders to exclude a substantial portion, and in some cases all, of the gain from federal tax on a sale if the statutory requirements are satisfied. After the July 2025 changes in the One Big Beautiful Bill Act, the conversation is no longer limited to a single five-year milestone. The law now includes graded holding periods at three, four, and five years, which creates new planning opportunities and new room for mistakes.
That shift is especially important for founders and investors who are making decisions in real time. A secondary sale at year three, an early acquisition offer, a conversion event, or a pre-exit recap can now produce different federal outcomes depending on the exact issuance date, the exact holder, and whether the stock was QSBS from the start.
New York taxpayers need to look one level deeper.
Federal QSBS treatment does not answer the state question by itself. For NYC founders, employees, and investors, the state conformity issue can materially affect after-tax proceeds, and it is often missed until return preparation. A deal that looks efficient on the federal side can still leave a meaningful New York tax cost in place. That is one of the first trade-offs I flag when reviewing a cap table or proposed transaction.
Many shareholders hear only the simplified version of QSBS. Hold the stock long enough and you may get a large tax benefit. In practice, the useful analysis starts earlier and goes further. The company's status, the way the shares were acquired, the timing of each issuance, and the state filing position all shape whether Section 1202 helps or disappoints.
The Billion-Dollar Question Your Accountant Should Ask
A founder in SoHo gets an acquisition offer in year four. The price is strong, the buyer wants to move fast, and everyone around the table assumes QSBS will take care of the tax side. That is the moment I ask the question that should have been asked much earlier: what, exactly, was issued, to whom, and on what date?
QSBS planning starts before the term sheet, before the LLC conversion, before the recap, and well before a sale process begins. Once a buyer is in diligence, the tax result is often set by old formation documents, board consents, subscription records, and equity grants that no one reviewed with Section 1202 in mind.
At a high level, qualified small business stock is stock issued by an eligible U.S. C corporation that meets the requirements of Section 1202. If the corporation and the shareholder both qualify, some or all of the gain on a later sale may be excluded for federal income tax purposes.
Practical rule: Treat QSBS as a tax design issue at issuance, not as a cleanup exercise before closing.
The questions that matter
When I review QSBS exposure for founders, early employees, and investors, I focus on five threshold questions first:
- Entity status: Was the company a domestic C corporation on the date the shares were issued?
- Issuance history: What was issued in each round, on which exact dates, and to which holder?
- Business activity: Was the corporation engaged in a qualifying trade or business during the required periods?
- Acquisition method: Did the holder receive shares at original issuance, or acquire them from another shareholder?
- New York tax cost: If the federal exclusion applies, does New York follow that treatment for this taxpayer?
Those questions sound basic. They decide outcomes.
A strong company is not automatically a qualified small business under Section 1202. I have seen well-funded companies with excellent exits lose part of the expected benefit because stock was issued before a C corporation conversion, because redemptions created problems, or because the holder bought shares secondhand and assumed the tax result traveled with the stock.
Why the 2025 changes deserve attention now
The One Big Beautiful Bill Act changed the timing analysis for stock issued on or after July 4, 2025. The old five-year conversation is no longer the whole conversation. We now have graded federal holding periods at three, four, and five years, which means an exit before year five may still produce a partial exclusion if the shares qualify and the dates line up.
That creates opportunity, but it also creates traps. For a founder considering an early sale, an investor buying into a later round, or an employee exercising and holding, the difference between issuance date, vesting date, exercise date, and sale date now matters even more. In practice, recordkeeping begins to drive tax value.
For New York City taxpayers, there is a second layer. Federal treatment does not settle the state result. New York conformity has to be reviewed separately, and that review should happen before the deal model is final. I raise this early because a transaction that looks tax-efficient on the federal return can still leave a meaningful New York State and New York City tax bill.
The Five Pillars of QSBS Eligibility
A QSBS file usually turns on five tests. Miss one, and the exclusion can collapse or shrink under IRS scrutiny. For founders and investors planning around the post-July 2025 rules, that matters even more because an earlier exit may now produce a partial federal benefit. The stock still has to qualify first.

The company must be a domestic C corporation
Section 1202 applies to stock issued by a domestic C corporation. Stock issued while the business was an LLC, partnership, or S corporation does not become QSBS just because the company later converts.
That point drives a surprising amount of cleanup work in venture-backed companies. A founder may start as an LLC, issue equity or profits interests, then convert when institutional money arrives. At that stage, the tax answer depends on the exact instrument, the conversion mechanics, and the date the C corporation stock was issued. Intent does not fix a bad issuance history.
I tell clients to review the cap table like a tax document, not just a corporate one.
The company must satisfy the gross asset test
The corporation has to meet a gross asset ceiling at the relevant time. For stock issued before July 4, 2025, the traditional threshold is $50 million. For stock issued on or after July 4, 2025, the threshold increases to $75 million.
This test is measured before and immediately after issuance, so timing matters. A financing that looks harmless from a business standpoint can change the tax result if cash arrives in the wrong sequence or if contributed property is valued aggressively. In practice, I see problems less from abusive planning and more from weak support for board valuations, incomplete balance sheet records, and sloppiness around closing dates.
For New York founders, this is often where federal and state modeling starts to drift apart. The federal QSBS question asks whether the stock qualifies under Section 1202. New York then raises a separate conformity question on the eventual gain. Those are different issues, and both should be modeled before the round closes.
The business must be an active qualified trade or business
This is usually the hardest pillar because the statute excludes several lines of business and applies an asset-use test that can get technical fast. The corporation generally needs to use a substantial portion of its assets in the active conduct of a qualified trade or business. Some sectors fit cleanly. Others do not.
Banking, insurance, financing, leasing, investing, farming, mining, and lodging-related businesses often raise immediate concerns. A software company selling a product usually has a cleaner story than a business earning fees that look like financial services income.
The edge cases matter.
Life sciences companies often require a closer review of how assets are used, what activities are being conducted, and whether the business has moved beyond a passive IP holding structure. Fintech and crypto companies need even more care. Labels do not decide the answer. Revenue model, licensing posture, custody arrangements, balance sheet use, and the company's actual operations all matter. A fintech company building software for financial institutions may have a stronger QSBS position than a company whose economics depend on spread income or activities that resemble excluded financial businesses.
One practical screen helps early:
- Stronger candidates: software, manufacturing, retail, and wholesaling
- Higher-risk candidates: banking, insurance, financing, leasing, investing, farming, mining, and lodging
- Fact-intensive candidates: biotech, life sciences, fintech, and crypto businesses with mixed operations
The shareholder must acquire the stock at original issuance
QSBS generally requires original issuance. Founders who receive stock from the corporation and investors who buy newly issued shares from the company are usually in the right lane. A buyer in a secondary transaction usually is not.
This becomes a real issue in later-stage deals and tender offers. I have seen buyers assume that if the company is a QSBS company, any share of its stock carries the same tax profile. It does not. The path the holder took into the cap table can determine whether Section 1202 is available at all.
Transfers by gift, inheritance, and certain partnership structures can preserve or complicate treatment, but those are technical exceptions that deserve separate review before anyone relies on them.
The holding period must be satisfied
Holding period analysis now needs more precision than it did a year ago. For older issuances, the familiar benchmark remains a five-year hold for the full exclusion. For stock issued on or after July 4, 2025, the federal rules now allow graded exclusions at three, four, and five years, assuming the stock qualifies in the first place.
That change creates planning room, but it also puts pressure on the records. Founders exercising options, employees early exercising restricted stock, and investors buying in multiple rounds need lot-by-lot tracking. Issue date, exercise date, vesting terms, transfer restrictions, and board approvals all belong in the file. If those records are missing, diligence gets expensive and the tax position gets weaker.
For NYC taxpayers, one more caution applies. A partial or full federal QSBS exclusion does not answer the New York State or New York City result by itself. State conformity still has to be checked separately before the sale model is treated as final.
Calculating Your Potential Tax Exclusion
A founder sells part of her position in late 2028. One lot was issued before July 2025. Another was issued after a financing closed that summer. The tax result can be very different even if both lots sit in the same cap table and are sold to the same buyer.
That is why QSBS modeling starts with the stock certificate, not the headline.
The exclusion percentage turns on issuance date, then holding period
For many shareholders, the baseline rule is still familiar. Stock issued after September 27, 2010 can qualify for a 100% federal exclusion once the applicable holding period is met, assuming the rest of Section 1202 is satisfied. Earlier issuances follow the older 50% and 75% regimes.
The practical change for current planning is the post-July 2025 framework described earlier in this article. For stock issued on or after July 4, 2025, the federal benefit is no longer limited to an all-or-nothing five-year outcome. The law now allows a partial exclusion after three years, a larger exclusion after four years, and the full exclusion after five years.
For founders and investors, that matters most when liquidity arrives on someone else's schedule. A strategic sale, tender offer, or recapitalization may happen before year five. Under the newer federal rules, an earlier exit can still preserve meaningful tax value if the shares otherwise qualify.
The cap matters as much as the percentage
After the exclusion percentage, the next question is the limitation. For older issuances, the familiar federal cap is the greater of $10 million or 10 times adjusted basis, applied per taxpayer and per issuer. For post-July 4, 2025 issuances, this article assumes the newer federal framework described above also raises that fixed-dollar cap to $15 million, with inflation adjustments, while retaining the 10 times basis alternative.
That detail changes the math for different holders in different ways.
A founder with a very low basis often focuses on the fixed-dollar cap because basis may be too small to make the 10 times basis test attractive. A later-stage investor who paid a meaningful purchase price may get more value from the basis-based cap. Family offices and spouses selling separate holdings also need to analyze who the taxpayer is for cap purposes before treating the available exclusion as a single pooled amount.
A workable way to model the result
Start with the lot being sold. Then test four variables in order:
| Question | Why it matters |
|---|---|
| When was the stock issued? | This determines which federal exclusion regime applies |
| How long has that specific lot been held? | Post-July 2025 shares may qualify for a partial or full exclusion depending on the holding period |
| What is the realized gain on that lot? | The exclusion only shelters eligible gain |
| Which cap is larger for this taxpayer and issuer? | The fixed-dollar cap and the 10 times basis cap can produce very different results |
A simple model helps:
Eligible exclusion = lesser of
- Applicable exclusion percentage × eligible gain, or
- Applicable taxpayer cap for that issuer
That formula is straightforward. The records behind it usually are not.
Exercise dates, conversion documents, stock powers, SAFEs that became equity, and round-by-round purchases can all create separate lots with separate holding periods and separate basis. In diligence, I often see clients model the sale at the account level when the statute applies at the share-lot level. That shortcut creates bad numbers.
Federal benefit does not answer the New York result
For NYC taxpayers, planning often goes sideways here. A strong federal QSBS result does not mean New York State and New York City will match it.
New York conformity has to be checked separately for the year of sale and for the specific version of the federal rule at issue. That is especially important under the post-July 2025 graded holding period framework. If federal law allows a partial exclusion at three or four years, taxpayers still need to confirm whether New York follows that treatment, decouples from it, or applies it differently in practice. The state answer can materially change estimated payments, transaction modeling, and the net value of an early exit.
For a New York founder deciding whether to sell at year four instead of waiting for year five, that is not a technical footnote. It can change the economics of the deal.
QSBS in Action Real World Scenarios
The best way to understand what is qualified small business stock is to test it against actual decision points. Not all holders benefit in the same way, and not all exits produce the same planning result.
A founder with a very low basis
A founder typically receives common stock early, often before the company has substantial enterprise value. That creates a simple but powerful dynamic. If the stock qualifies and the basis is low, the 10 times adjusted basis framework can become highly relevant.
In that fact pattern, the founder's planning focus usually isn't whether the benefit is meaningful. It usually is. The primary work is proving that the issuance date, entity status, and active business requirement were all satisfied when the shares were acquired and during the relevant holding period.
What tends to work:
- Clean formation records
- A timely stock issuance trail
- Consistent treatment across cap table software, board approvals, and tax filings
What tends to fail:
- Sloppy conversion records from an LLC to a C corporation
- Missing grant paperwork
- Assuming all founder shares have the same holding period when they were issued in separate lots
An angel investor in a seed round
For an angel, the appeal of QSBS is usually more straightforward. The investor subscribes directly for newly issued stock, holds the position, and hopes for asymmetric upside. The tax question becomes whether the gain falls within the applicable cap and whether the company remained inside the statutory requirements.
The post-July 2025 rules are significant. A seed investor who buys newly issued shares after that date may have a federal planning option even if the exit occurs before year five. The 3-year and 4-year exclusion tiers can materially change how the investor evaluates acquisition offers, tender opportunities, and rollover alternatives.
The right investor memo doesn't just describe upside. It records how the shares were acquired and whether the company represented itself as tracking QSBS eligibility.
A family office building a direct investment program
Family offices often look at QSBS differently from individual angels. They're not just evaluating one company. They're building a repeatable process across multiple direct investments.
That means the useful question isn't "Does this company qualify?" It's "Can our diligence process identify when qualification is plausible, when it is doubtful, and what documents we need before wiring funds?"
A disciplined family office usually wants:
- Entity confirmation: Proof the issuer is a domestic C corporation.
- Issuance confirmation: Evidence the shares are acquired directly from the company.
- Operational support: Internal materials or legal analysis supporting the active business position.
- State modeling: A separate projection for federal treatment and New York consequences.
The family office that does this upfront has options later. The office that ignores it usually discovers the issue only when a portfolio company exits and everyone starts asking for support letters that were never requested.
Navigating State Taxes AMT and Rollover Rules
A Manhattan founder sells stock after four years, hears "partial federal exclusion," and assumes the tax story is mostly favorable. Then the New York projection shows a very different answer. That gap is where QSBS planning often breaks down.

Federal treatment and New York treatment are separate analyses
For New York clients, I usually model QSBS twice. First under federal law. Then under New York law, including New York City where relevant.
That distinction matters more after the July 2025 One Big Beautiful Bill Act changes. The new 3-year, 4-year, and 5-year federal holding period tiers can improve the federal result on an earlier exit, but they do not mean New York follows the same path. A founder with a real federal exclusion can still owe substantial state and city tax.
For NYC taxpayers, that difference changes negotiations. It affects how you evaluate a sale before year five, whether a tender offer is attractive, and how much cash you should reserve before closing.
A good federal QSBS result can still leave a painful New York bill.
AMT is no longer the old headline issue for many taxpayers
Older QSBS commentary often overstates the AMT problem because it reflects earlier issuance periods and older exclusion rules. For many holders of later-issued shares that qualify for full federal exclusion, the classic AMT concern is much less important than it used to be.
That does not mean AMT disappears from return preparation. It means the analysis has to be tied to the actual issuance date, the applicable exclusion regime, and the rest of the taxpayer's return. I do not treat AMT as a default QSBS penalty. I test it based on the facts.
The practical mistake is assuming all QSBS stock creates the same AMT profile. It does not.
Section 1045 still matters, especially under the new graded holding periods
Section 1045 remains relevant if stock is sold before the full 5-year hold and the taxpayer wants to defer gain by rolling proceeds into replacement QSBS within the statutory window. That rule was already useful before July 2025. It now sits in a more nuanced planning framework.
Why? Because an early sale is no longer a simple yes-or-no question under federal law. A taxpayer may now be comparing three live options at once:
- Sell after 3 years and claim the available partial federal exclusion
- Hold longer to improve the federal percentage at year 4 or year 5
- Sell earlier and use Section 1045 to defer gain into replacement QSBS
Each path has trade-offs. A Section 1045 rollover can preserve federal tax value, but it requires careful reinvestment timing, clean tracing of proceeds, and confidence that the replacement shares qualify. For a New York resident, it also does not solve the separate state conformity question by itself.
A rushed rollover often creates new diligence risk instead of a clean deferral strategy.
What NYC-based stakeholders should model before signing
For founders, investors, and family offices based in New York City, I usually want three workstreams running at the same time:
- Federal QSBS analysis: Does the stock qualify, and which holding-period tier applies after the 2025 law changes?
- New York and NYC exposure: Does the state conform, what income remains taxable locally, and how does residency affect the result?
- Exit timing and rollover planning: Is it better to close now, wait for a better federal tier, or structure around Section 1045?
The recurring problem is incomplete modeling. Someone focuses on the federal exclusion, ignores New York, and gives the board or the seller a number that is too optimistic. At this level, that is not a rounding error. It is a planning failure.
Proactive QSBS Planning for Founders and Investors
QSBS is rarely something you "discover" at the end. The best outcomes come from deliberate planning while the company is still private and before the documents are hard to fix.

Start with structure, not cleanup
The cleanest QSBS planning starts with entity choice. If the company expects to issue equity to founders, employees, or outside investors, the C corporation question should be addressed early. Trying to retrofit a QSBS strategy after years of operating in a different form usually produces complexity, not elegance.
For founders, this also means paying attention to how shares are issued. A cap table is not proof by itself. Board consents, subscription agreements, stock certificates or their digital equivalent, and tax elections all need to align.
Keep records like diligence starts tomorrow
A surprising amount of QSBS value is lost because the taxpayer can't prove the facts cleanly. The issue isn't that the company necessarily failed the test. The issue is that years later nobody can show what happened.
I usually want clients to preserve a focused QSBS file that includes:
- Formation documents: Proof of domestic C corporation status at issuance.
- Asset snapshots: Support for the applicable gross asset test at the issuance date.
- Issuance records: Board approvals, subscription paperwork, and cap table entries.
- Business activity support: Materials showing the company was engaged in a qualified active business.
- Holder-specific tracking: Separate records for each lot, each holder, and each transfer event.
Good QSBS files are boring. That's exactly what you want when a buyer, auditor, or tax authority asks questions years later.
Watch the mistakes that quietly destroy the benefit
The most expensive QSBS problems are usually technical, not dramatic.
Here are a few that come up repeatedly:
- Secondary purchases: Buying from another shareholder instead of directly from the company can undercut eligibility.
- Redemptions and buybacks: Certain stock redemptions can create disqualification issues and need review before they happen.
- Late 83(b) attention: For founder equity and restricted stock, the timing of an 83(b) election can affect when the holding period begins. If that election is missed where it was otherwise appropriate, the tax clock may not work the way the founder assumes.
- Business drift: A company that starts in a qualifying lane and later shifts toward excluded activity can create problems during the holding period.
- Fundraising without tax coordination: Capital events can affect the asset test and should be reviewed in context, not just papered by counsel in isolation.
What disciplined planning looks like
The strongest QSBS planning is collaborative. Corporate counsel handles formation and issuance mechanics. The tax advisor pressure-tests Section 1202 assumptions. The finance team maintains support that can survive a later transaction.
That matters because what is qualified small business stock isn't just a definitional question. It's a documentation question, a timing question, and a discipline question. Founders and investors who treat it that way usually preserve options. Those who treat it as a headline tax perk often learn, very late, that the details were the entire story.
Is Your Stock QSBS Next Steps with Blue Sage
QSBS can be one of the most valuable tax benefits available to founders, investors, and family offices. It can also fail for reasons that are entirely preventable. The issue is rarely the concept. The issue is execution, recordkeeping, and knowing where federal and New York rules part ways.
If you think you may hold qualifying stock, or you're investing with QSBS in mind, get the facts reviewed before the liquidity event. Even a simple visual illustration of tax planning considerations is more useful when it's backed by entity records, issuance documents, and a state-level analysis.
Blue Sage Tax & Accounting Inc. helps founders, investors, and New York family offices evaluate QSBS eligibility, model federal and state outcomes, and build documentation that stands up under scrutiny. If you want a practical review of your stock history, entity structure, or upcoming exit, schedule a consultation with Blue Sage Tax & Accounting Inc..